Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | NPC1 | O15118 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 4/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.59 |
| ▸ | TYR | P14679 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | DPP4 | P27487 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1711780 | 1.00 | KDM4E (1.00) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL11683046 | 0.86 | KDM4E (0.76) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL11253542 | 0.86 | KDM4E (0.75) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL11253548 | 0.86 | KDM4E (0.75) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| Cinnamic Acid SCHEMBL10932316 | 0.85 | KDM4E (0.73) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| Cinnamic Acid SCHEMBL10932313 | 0.85 | KDM4E (0.73) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL7140088 | 0.85 | KDM4E (0.73) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL12814412 | 0.85 | KDM4E (0.73) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL4322158 | 0.85 | KDM4E (0.73) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL28002416 | 0.85 | KDM4E (0.73) | KDM4EMAPK1SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115449900-B | Texturing treating agent, preparation method thereof and method for texturing monocrystalline silicon wafer | 浙江奥首材料科技有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-114163313-B | Method for selectively synthesizing EZ-stilbene by coupling ruthenium-catalyzed aryl diazonium salt with cinnamic acid | 中山大学 | 2023-11-03 | — | — | CN | claimed |
| CN-115449900-A | Texturing treating agent, preparation method thereof and method for texturing monocrystalline silicon wafer | 浙江奥首材料科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-114163313-A | Method for selectively synthesizing EZ-stilbene by coupling aryl diazonium salt and cinnamic acid under catalysis of ruthenium | 中山大学 | 2022-03-11 | — | — | CN | claimed |
| EP-2967038-B1 | METHODS, COMPOUNDS AND COMPOSITIONS FOR REPELLING INSECTS AND ARACHNIDS | NATIONAL CENTER FOR SCIENT RESEARCH DEMOKRITOS (GR) | 2019-05-08 | — | — | EP | claimed |
| EP-1429768-B1 | NOVEL MEDICAMENTS FOR INHALATION | BOEHRINGER INGELHEIM PHARMA (DE) | 2016-11-16 | — | — | EP | claimed |
| US-20160029643-A1 | Methods, Compounds and Compositions for Repelling Insects and/or Arachnids | NATIONAL CENTER FOR SCIENTIFIC RESEARCH "DEMOKRITOS" (GB) | 2016-02-04 | — | — | US | claimed |
| EP-2967038-A2 | METHODS, COMPOUNDS AND COMPOSITIONS FOR REPELLING INSECTS AND ARACHNIDS | NATIONAL CENTER FOR SCIENTIFIC RESEARCH "DEMOKRITOS" (GR) | 2016-01-20 | — | — | EP | claimed |
| WO-2014140314-A2 | METHODS, COMPOUNDS AND COMPOSITIONS FOR REPELLING INSECTS AND/OR ARACHNIDS | UNIVERSITE DE NEUCHATEL (CH) | 2014-09-18 | — | — | WO | claimed |
| US-20070093558-A1 | Electrostatic aerosol compositions | RECKITT BENCKISER (UK) LIMITED, A UK CORPORATION | 2007-04-26 | — | — | US | claimed |
| EP-1747059-A1 | PERVAPORATION COMPOSITE MEMBRANES | McMaster University (CA) | 2007-01-31 | — | — | EP | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| US-20050256149-A1 | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-11-17 | — | — | US | claimed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | claimed |
| US-6919325-B2 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-07-19 | — | — | US | claimed |
| EP-1409605-A2 | ELECTROSTATIC AEROSOL COMPOSITIONS | Reckitt Benckiser (U.K.) LIMITED (GB) | 2004-04-21 | — | — | EP | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
| US-20030096878-A1 | Electrostatic aerosol compositions | RECKITT BENCKISER (UK) LIMITED | 2003-05-22 | — | — | US | claimed |
| WO-2001018145-A2 | ELECTROSTATIC AEROSOL COMPOSITIONS | RECKITT BENCKISER (UK) LIMITED (GB) | 2001-03-15 | — | — | WO | claimed |
| US-5961875-A | Antifreeze/coolant composition containing cinnamic acid | CCI CO., LTD. (JP) | 1999-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256149-A1 | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts | ADRB3, ADRB1, HSD3B1 | KDM4E 4185/4885MAPK1 2552/4885SMN1; SMN2 1739/4885 |
| US-20160029643-A1 | Methods, Compounds and Compositions for Repelling Insects and/or Arachnids | ACHE, NISCH, BCHE | KDM4E 2793/4885MAPK1 3792/4885SMN1; SMN2 2488/4885 |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | ADRB3, ADRB1, CHRM3 | KDM4E 4788/4885MAPK1 2904/4885SMN1; SMN2 1191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.